Anorexia nervosa medical issues

Journal of Women's Health

Volumn 12, Issue 4, 2003, Pages 331-340

  Mehler, Philip S ^a   Krantz, Mori ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CALCIUM; CISAPRIDE; ESTROGEN; LACTULOSE; LAXATIVE; METOCLOPRAMIDE; NEUROLEPTIC AGENT; ORAL CONTRACEPTIVE AGENT; PROKINETIC AGENT; VITAMIN D;

ADULT; AMENORRHEA; ANOREXIA NERVOSA; BODY WEIGHT; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CONSTIPATION; DIET THERAPY; ENDOCRINE DISEASE; FEMALE; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HEMATOLOGIC DISEASE; HUMAN; LONG QT SYNDROME; MENTAL DISEASE; METABOLIC DISORDER; OSTEOPOROSIS; PRIMARY HEALTH CARE; PRIORITY JOURNAL; REFEEDING; REVIEW;

EID: 0038173804     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/154099903765448844     Document Type: Review

References (89)

1. Lucas AR, Beard CM, O'Fallon WM, Kurland LT. 50-year trends in the incidence of anorexia nervosa in Rochester, Minn: A population-based study. Am J Psychiatry 1991;148:917.
2. Hsu LK. Epidemiology of the eating disorders. Psychiatr Clin North Am 1996;19:681.
3. Fairburn CG, Cooper Z, Doll HA, Welch SL. Risk factors for anorexia nervosa: Three integrated case-control comparisons. Arch Gen Psychiatry 1999;56:468.
4. Pryor T. Diagnostic criteria for eating disorders: DSMIV revision. Psychiatry Annu 1995;25:40.
5. Sullivan PF. Mortality in anorexia nervosa. Am J Psychiatry 1995;152:1073.
6. Herzog DB, Greenwood DN, Dorer DJ, et al. Mortality in eating disorders: A descriptive study. Int J Eat Disord 2000;28:20.
7. Zipfel S, Lowe B, Reas DL, Deter HC, Herzog W. Long-term prognosis in anorexia nervosa: Lessons from a 21-year follow-up study. Lancet 2000;355:721.
8. Fichter MM, Quadflieg N. Six-year course and outcome of anorexia nervosa. Int J Eat Disord 1999;26:359.
9. Schocken DD, Holloway JD, Powers PS. Weight loss and the heart. Effects of anorexia nervosa and starvation. Arch Intern Med 1989;149:877.
10. Isager T, Brinch M, Kreiner S, Tolstrup K. Death and relapse in anorexia nervosa: Survival analysis of 151 cases. J Psychiatr Res 1985;19:515.
11. Keys A, Henschel A, Taylor HL. The size and function of the human heart at rest in semistarvation and in subsequent rehabilitation. Am J Phys 1947;150:153.
12. Kollai M, Bonyhay I, Jokkel G, Szonyi L. Cardiac vagal hyperactivity in adolescent anorexia nervosa. Eur Heart J 1994;15:1113.
13. Nudel DB, Gootman N, Nussbaum MP, Shenker IR. Altered exercise performance and abnormal sympathetic responses to exercise in patients with anorexia nervosa. J Pediatr 1984;105:34.
14. Cooke RA, Chambers JB. Anorexia nervosa and the heart. Br J Hosp Med 1995;54:313.
15. Johnson GL, Humphries LL, Shirley PB, Mazzoleni A, Noonan JA. Mitral valve prolapse in patients with anorexia nervosa and bulimia. Arch Intern Med 1986; 146:1525.
16. de Simone G, Scalfi L, Galderisi M, et al. Cardiac abnormalities in young women with anorexia nervosa. Br Heart J 1994;71:287.
17. Birmingham CL, Stigant C, Goldner EM. Chest pain in anorexia nervosa. Int J Eat Disord 1999;25:219.
18. Heymsfield SB, Bethel RA, Ansley JD, Gibbs DM, Felner JM, Nutter DO. Cardiac abnormalities in cachectic patients before and during nutritional repletion. Am Heart J 1978;95:584.
19. Hall RC, Hoffman RS, Beresford TP, Wooley B, Hall AK, Kubasak L. Physical illness encountered in patients with eating disorders. Psychosomatics 1989;30: 174.
20. Powers PS. Heart failure during treatment of anorexia nervosa. Am J Psychiatry 1982;139:1167.
21. Kohn MR, Golden NH, Shenker IR. Cardiac arrest and delirium: Presentations of the refeeding syndrome in severely malnourished adolescents with anorexia nervosa. J Adolesc Health 1998;22:239.
22. Birmingham CL, Alothman AF, Goldner EM. Anorexia nervosa: Refeeding and hypophosphatemia. Int J Eat Disord 1996;20:211.
23. Fisher M, Simpser E, Schneider M. Hypophosphatemia secondary to oral refeeding in anorexia nervosa. Int J Eat Disord 2000;28:181.
24. Frolich J, von Gontard A, Lehmkuhl G, Pfeiffer E, Lehmkuhl U. Pericardial effusions in anorexia nervosa. Eur Child Adolesc Psychiatry 2001;10:54.
25. Mehler PS, Lezotte D, Eckel R. Lipid levels in anorexia nervosa. Int J Eat Disord 1998;24:217.
26. Isner JM, Roberts WC, Heymsfield SB, Yager J. Anorexia nervosa and sudden death. Ann Intern Med 1985;102:49.
27. U.S. Department of Health and Human Services. Eating disorders. Washington, DC: U.S. Department of Health and Human Services. 1993:93.
28. Dessertenne F. [Ventricular tachycardia with 2 variable opposing foci.] Arch Mal Coeur 1966;59:263.
29. Cooke RA, Chambers JB, Singh R, et al. QT interval in anorexia nervosa. Br Heart J 1994;72:69.
30. Durakovic Z, Durakovic A, Korsic M. Changes of the corrected Q-T interval in the electrocardiogram of patients with anorexia nervosa. Int J Cardiol 1994;45:115.
31. Thurston J, Marks P. Electrocardiographic abnormalities in patients with anorexia nervosa. Br Heart J 1974;36:719.
32. Palla B, Litt IF. Medical complications of eating disorders in adolescents. Pediatrics 1988;81:613.
33. Swenne I, Larsson PT. Heart risk associated with weight loss in anorexia nervosa and eating disorders: Risk factors for QTc interval prolongation and dispersion. Acta Paediatr 1999;88:304.
34. Dec GW, Biederman J, Hougen TJ. Cardiovascular findings in adolescent inpatients with anorexia nervosa. Psychosom Med 1987;49:285.
35. Gottdiener JS, Gross HA, Henry WL, Borer JS, Ebert MH. Effects of self-induced starvation on cardiac size and function in anorexia nervosa. Circulation 1978;58: 425.
36. Powers PS, Schocken DD, Feld J, Holloway JD, Boyd FR. Cardiac function during weight restoration in anorexia nervosa. Int J Eat Disord 1991;10:521.
37. Vanderdonckt O, Lambert M, Montero MC, Boland B, Brohet C. The 12-lead electrocardiogram in anorexia nervosa: A report of 2 cases followed by a retrospective study. J Electrocardiol 2001;34:233.
38. Liu XK, Wang W, Ebert SN, Franz MR, Katchman A, Woosley RL. Female gender is a risk factor for torsades de pointes in an in vitro animal model. J Cardiovasc Pharmacol 1999;34:287.
39. Viskin S. Long QT syndromes and torsade de pointes. Lancet 1999;354:1625.
40. Wolbrette D, Patel H. Arrhythmias and women. Curr Opin Cardiol 1999;14:36.
41. Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 1993;270:2590.
42. Wolbrette D, Naccarelli G, Curtis A, Lehmann M, Kadish A. Gender differences in arrhythmias. Clin Cardiol 2002;25:49.
43. Greenfeld D, Mickley D, Quinlan DM, Roloff P. Hypokalemia in outpatients with eating disorders. Am J Psychiatry 1995;152:60.
44. Mehler PS. Electrolyte disorders in bulimia. Eat Disord Treat Prev 1998;6:65.
45. Isner JM, Sours HE, Paris AL, Ferrans VJ, Roberts WC. Sudden, unexpected death in avid dieters using the liquid-protein-modified fast diet. Observations in 17 patients and the role of the prolonged QT interval. Circulation 1979;60:1401.
46. Best TH, Franz DN, Gilbert DL, Nelson DP, Epstein MR. Cardiac complications in pediatric patients on the ketogenic diet. Neurology 2000;54:2328.
47. Kurita T, Ohe T, Shimizu W, et al. Early after-depolarization-like activity in patients with class IA induced long QT syndrome and torsades de pointes. PACE 1997;20:695.
48. Wesley RC Jr, Turnquest P. Torsades de pointe after intravenous adenosine in the presence of prolonged QT syndrome. Am Heart J 1992;123:794.
49. Gull WW. Anorexia nervosa. Trans Clin Soc Lond 1874;7:22.
50. Platte P, Pirke KM, Trimborn P, Pietsch K, Krieg JC, Fichter MM. Resting metabolic rate and total energy expenditure in acute and weight recovered patients with anorexia nervosa and in healthy young women. Int J Eat Disord 1994;16:45.
51. Krahn DD, Rock C, Dechert RE, Nairn KK, Hasse SA. Changes in resting energy expenditure and body composition in anorexia nervosa patients during refeeding. J Am Diet Assoc 1993;93:434.
52. Salisbury JJ, Levine AS, Crow SJ, Mitchell JE. Refeeding, metabolic rate, and weight gain in anorexia nervosa: A review. Int J Eat Disord 1995;17:337.
53. Obarzanek E, Lesem MD, Jimerson DC. Resting metabolic rate of anorexia nervosa patients during weight gain. Am J Clin Nutr 1994;60:666.
54. Pauly RP, Lear SA, Hastings FC, Birmingham CL. Resting energy expenditure and plasma leptin levels in anorexia nervosa during acute refeeding. Int J Eat Discord 2000;28:231.
55. Jeejeebhoy KN. Nutritional management of anorexia. Semin Gastrointest Dis 1998;9:183.
56. Mehler PS, Weiner KL. Anorexia nervosa and total parenteral nutrition. Int J Eat Disord 1993;14:297.
57. Melchior JC. From malnutrition to refeeding during anorexia nervosa. Curr Opin Clin Nutr Metab Care 1998;1:481.
58. Golden NH, Jacobson MS, Schebendach J, Solanto MV, Hertz SM, Shenker IR. Resumption of menses in anorexia nervosa. Arch Pediatr Adolesc Med 1997; 151:16.
59. White CM, Hergenroeder AC, Klish WJ. Bone mineral density in 15- to 21-year-old eumenorrheic and amenorrheic subjects. Am J Dis Child 1992;146:31.
60. Lucas AR, Melton LJ III, Crowson CS, C'Fallon WM. Long-term fracture risk among women with anorexia nervosa: A population-based cohort study. Mayo Clin Proc 1999;74:972.
61. Soyka LA, Grinspoon S, Levitsky LL, Herzog DB, Klibanski A. The effects of anorexia nervosa on bone metabolism in female adolescents. J Clin Endocrinol Metab 1999;84:4489.
62. Grinspoon S, Thomas E, Pitts S, et al. Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med 2000;133:790.
63. Lennkh C, de Zwaan M, Bailer U, et al. Osteopenia in anorexia nervosa: Specific mechanisms of bone loss. J Psychiatr Res 1999;33:349.
64. Grinspoon S, Miller K, Coyle C, et al. Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. J Clin Endocrinol Metab 1999;84:2049.
65. Mehler PS, Eckel RH, Donahoo WT. Leptin levels in restricting and purging anorectics. Int J Eat Disord 1999;26:189.
66. Mundy GR. Secondary osteoporosis: The potential relevance of leptin and low body weight. Ann Intern Med 2000;133:828.
67. Boyar RM, Hellman LD, Roffwarg H, et al. Cortisol secretion and metabolism in anorexia nervosa. N Engl J Med 1977;296:190.
68. Andersen AE, Woodward PJ, LaFrance N. Bone mineral density of eating disorder subgroups. Int J Eat Disord 1995;18:335.
69. Iketani T, Kiriike N, Nakanishi S, Nakasuji T. Effects of weight gain and resumption of menses on reduced bone density in patients with anorexia nervosa. Biol Psychiatry 1995;37:521.
70. Hergenroeder AC. Bone mineralization, hypothalamic amenorrhea, and sex steroid therapy in female adolescents and young adults. J Pediatr 1995;126:683.
71. National Osteoporosis Foundation. Physicians' guide to prevention and treatment of osteoporosis. Bell Mead, NJ: Excerpta Medica, 1998.
72. Cummings SR, Palermo L, Browner W, et al. Monitoring osteoporosis therapy with bone densitometry: Misleading changes and regression to the mean. Fracture Intervention Trial Research Group. JAMA 2000; 283:1318.
73. Wong JC, Lewindon P, Mortimer R, Shepherd R. Bone mineral density in adolescent females with recently diagnosed anorexia nervosa. Int J Eat Disord 2001;29:11.
74. Baker D, Roberts R, Towell T. Factors predictive of bone mineral density in eating-disordered women: A longitudinal study. Int J Eat Disord 2000;27:29.
75. Bone HG, Greenspan SL, McKeever C, et al. Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group. J Clin Endocrinol Metab 2000;85: 720.
76. Rigotti NA, Nussbaum SR, Herzog DB, Neer RM. Osteoporosis in women with anorexia nervosa. N Engl J Med 1984;311:1601.
77. Klibanski A, Biller BM, Schoenfeld DA, Herzog DB, Saxe VC. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab 1995;80:898.
78. 3 supplementation prevents bone loss in the spine secondary to lowdose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1996;125:961.
79. Adachi JD, Bensen WG, Brown J, et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 1997;337:382.
80. Norre J, Vandereycken W, Gordts S. The management of eating disorders in a fertility clinic: Clinical guidelines. J Psychosom Obstet Gynaecol 2001;22:77.
81. Franko DL, Spurrell EB. Detection and management of eating disorders during pregnancy. Obstet Gynecol 2000;95:942.
82. Mehler PS. Eating disorders in medical care of the pregnant patient. Philadelphia: ACP Press, 2000.
83. Rich LM, Caine MR, Findling JW, Shaker JL. Hypoglycemic coma in anorexia nervosa. Case report and review of the literature. Arch Intern Med 1990;150: 894.
84. Stracher G, Bergmann H, Steiner-Mittelbach G, Kiss A, Abatzi TA. Primary anorexia nervosa - Gastric emptying and control motor activity. Int J Eat Disord 1994;14:297.
85. Richter JE. Cisapride: Limited access and alternatives. Cleve Clin J Med 2000;67:471.
86. Chun AB, Sokol MS, Kaye WH, Hutson WR, Wald A. Colonic and anorectal function in constipated patients with anorexia nervosa. Am J Gastroenterol 1997;92: 1879.
87. Mehler PS, Howe SE. Serous fat atrophy with leukopenia in severe anorexia nervosa. Am J Hematol 1995;49:171.
88. Mehler PS, Andersen AE. Eating disorders: Medical care and complications. Baltimore, MD: John Hopkins University Press, 2000.
89. Gowers SG, Weetman J, Shore A, Hossain F, Elvins R. Impact of hospitalisation on the outcome of adolescent anorexia nervosa. Br J Psychiatry 2000;176:138.